Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 434,433 | 60,000 | 26,581 | 27,357 | 28,628 |
| Gross Profit | 434,433 | 60,000 | 26,581 | 27,357 | 28,628 |
| Operating Expenses | 181,590 | 153,652 | 157,954 | 153,202 | 93,144 |
| Operating Income | 252,843 | -93,652 | -131,373 | -125,845 | -64,516 |
| Interest Expense | 0 | 0 | 0 | 0 | 598 |
| Other Income | 26,565 | 14,697 | 3,980 | 294 | 269 |
| Pre-tax Income | 279,408 | -78,955 | -127,393 | -125,551 | -64,845 |
| Income Tax | 4,220 | N/A | N/A | N/A | 1,305 |
| Net Income Continuous | 275,188 | -78,955 | -127,393 | -125,551 | -66,150 |
| Net Income | $275,188 | $-78,955 | $-127,393 | $-125,551 | $-66,150 |
| EPS Basic Total Ops | 4.47 | -1.39 | -2.60 | -2.71 | -1.92 |
| EPS Basic Continuous Ops | 4.47 | -1.39 | -2.60 | -2.71 | -1.92 |
| EPS Diluted Total Ops | 4.23 | -1.39 | -2.60 | -2.71 | -1.92 |
| EPS Diluted Continuous Ops | 4.23 | -1.39 | -2.60 | -2.71 | -1.92 |
| EPS Diluted Before Non-Recurring Items | 4.23 | -1.39 | -2.60 | -2.71 | -1.92 |
| EBITDA(a) | $246,863 | $-94,909 | $-128,553 | $-121,240 | $-61,756 |